Jacksonville Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$606K Buy
505
+7
+1% +$7.15K 0.34% 40
2026
Q1
$458K Buy
498
+2
+0.4% +$2.03K 0.31% 44
2025
Q4
$533K Hold
496
0.38% 45
2025
Q3
$378K Buy
496
+200
+68% +$149K 0.28% 50
2025
Q2
$231K Buy
+296
New +$230K 0.19% 62

Other funds holding LLY

Jacksonville Wealth Management's LLY Position: Q2 2026 in Review

Jacksonville Wealth Management increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $7.15K and bringing the position to 505 shares worth $606K. The position accounts for 0.34% of the portfolio, ranked #40.

Jacksonville Wealth Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jacksonville Wealth Management held 505 shares of Eli Lilly worth $606K as of Q2 2026.
  • Jacksonville Wealth Management bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.34% of Jacksonville Wealth Management's portfolio in Q2 2026, its #40 holding.
  • Jacksonville Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jacksonville Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.